Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The landscape of pharmaceutical development is continuously evolving, with a growing emphasis on precise and effective drug delivery. Lipid Nanoparticles (LNPs) have emerged as a leading platform for this purpose, particularly for nucleic acid-based therapeutics such as mRNA. At the forefront of LNP formulation is the careful selection of lipid components, among which 1,2-Distearoyl-sn-glycero-3-Phosphatidic acid sodium salt (DSPA) stands out due to its unique properties.
NINGBO INNO PHARMCHEM CO.,LTD. recognizes DSPA as a key ingredient for creating stable and functional LNPs. This phospholipid, characterized by its saturated stearic acid chains and a negatively charged phosphate headgroup, plays a crucial role in the structural integrity and payload encapsulation of these nanoparticles. Its ability to interact with other lipid components, including ionizable lipids and PEGylated lipids, allows for the formation of precise, stable nanoparticle structures essential for successful delivery.
The utility of DSPA extends beyond its structural contributions. As a phospholipid, it is inherently biocompatible, making it an excellent choice for pharmaceutical excipients. Research into biocompatible lipid excipients consistently points to compounds like DSPA for their favorable safety profiles, particularly in applications requiring administration to sensitive tissues or organs. Furthermore, the precise nature of synthetic phospholipids in research, such as DSPA, ensures lot-to-lot consistency, which is paramount for regulatory approval and scaled-up manufacturing processes.
Exploring DSPA lipid nanoparticle formulation reveals its versatility. It can be incorporated into various LNP architectures to optimize drug loading, release kinetics, and cellular uptake. The negative charge of the phosphatidic acid headgroup can influence the overall charge distribution of the LNP, impacting its interaction with biological membranes and cellular components. This makes it a valuable tool for scientists investigating 1,2-distearoyl-sn-glycero-3-phosphatidic acid sodium salt applications.
For researchers and manufacturers seeking high-quality DSPA, NINGBO INNO PHARMCHEM CO.,LTD. offers a reliable source. Our commitment to producing premium chemical intermediates ensures that your drug delivery projects benefit from the best possible components. Whether you are developing next-generation vaccines, gene therapies, or targeted small molecule drugs, incorporating DSPA can significantly enhance the efficacy and safety of your formulations. Discover the difference that quality ingredients make in advancing your therapeutic goals.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
